The βc receptor family - Structural insights and their functional implications - PubMed

Review

The βc receptor family - Structural insights and their functional implications

Sophie E Broughton et al. Cytokine. 2015 Aug.

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and IL-5 are members of a small family of cytokines that share a beta receptor subunit (βc). These cytokines regulate the growth, differentiation, migration and effector function activities of many hematopoietic cells in bone marrow, blood and sites of inflammation. Excessive or aberrant signaling can result in chronic inflammatory conditions and myeloid leukemias. The crystal structures of the GM-CSF ternary complex, the IL-5 binary complex and the very recent IL-3 receptor alpha subunit build upon decades of structure-function studies, giving new insights into cytokine-receptor specificity and signal transduction. Selective modulation of receptor function is now a real possibility and the structures of the βc receptor family are being used to discover novel and disease-specific therapeutics.

Keywords: Beta common receptor; Granulocyte–macrophage colony stimulating factor; Inflammation; Interleukin-3; Interleukin-5.

Similar articles

• IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.

  Murphy JM, Young IG. Murphy JM, et al. Vitam Horm. 2006;74:1-30. doi: 10.1016/S0083-6729(06)74001-8. Vitam Horm. 2006. PMID: 17027509 Review.

• The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.

  Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, Bonder CS, Lopez AF, Parker MW. Broughton SE, et al. Immunol Rev. 2012 Nov;250(1):277-302. doi: 10.1111/j.1600-065X.2012.01164.x. Immunol Rev. 2012. PMID: 23046136 Review.

• Clarification of the role of N-glycans on the common beta-subunit of the human IL-3, IL-5 and GM-CSF receptors and the murine IL-3 beta-receptor in ligand-binding and receptor activation.

  Murphy JM, Soboleva TA, Mirza S, Ford SC, Olsen JE, Chen J, Young IG. Murphy JM, et al. Cytokine. 2008 May;42(2):234-242. doi: 10.1016/j.cyto.2008.02.010. Epub 2008 Apr 18. Cytokine. 2008. PMID: 18374598

• CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.

  Panousis C, Dhagat U, Edwards KM, Rayzman V, Hardy MP, Braley H, Gauvreau GM, Hercus TR, Smith S, Sehmi R, McMillan L, Dottore M, McClure BJ, Fabri LJ, Vairo G, Lopez AF, Parker MW, Nash AD, Wilson NJ, Wilson MJ, Owczarek CM. Panousis C, et al. MAbs. 2016;8(3):436-53. doi: 10.1080/19420862.2015.1119352. Epub 2015 Dec 14. MAbs. 2016. PMID: 26651396 Free PMC article.

• Crystal structure of the mouse interleukin-3 β-receptor: insights into interleukin-3 binding and receptor activation.

  Carr PD, Ewens CL, Dai J, Ollis DL, Murphy JM, Jackson CJ, Young IG. Carr PD, et al. Biochem J. 2014 Nov 1;463(3):393-403. doi: 10.1042/BJ20140863. Biochem J. 2014. PMID: 25137390

Cited by

• Mechanism of Emodin in the Treatment of Rheumatoid Arthritis.

  Cheng L, Chen J, Rong X. Cheng L, et al. Evid Based Complement Alternat Med. 2022 Oct 3;2022:9482570. doi: 10.1155/2022/9482570. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36225183 Free PMC article. Review.

• Sequential control of myeloid cell proliferation and differentiation by cytokine receptor-based chimeric antigen receptors.

  Nakajima K, Shen Z, Miura M, Nakabayashi H, Kawahara M. Nakajima K, et al. PLoS One. 2022 Dec 27;17(12):e0279409. doi: 10.1371/journal.pone.0279409. eCollection 2022. PLoS One. 2022. PMID: 36574389 Free PMC article.

• DS-70, a novel and potent α₄ integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

  Dattoli SD, Baiula M, De Marco R, Bedini A, Anselmi M, Gentilucci L, Spampinato S. Dattoli SD, et al. Br J Pharmacol. 2018 Oct;175(20):3891-3910. doi: 10.1111/bph.14458. Epub 2018 Sep 17. Br J Pharmacol. 2018. PMID: 30051467 Free PMC article.

• The JAK-STAT pathway: from structural biology to cytokine engineering.

  Lv Y, Qi J, Babon JJ, Cao L, Fan G, Lang J, Zhang J, Mi P, Kobe B, Wang F. Lv Y, et al. Signal Transduct Target Ther. 2024 Aug 21;9(1):221. doi: 10.1038/s41392-024-01934-w. Signal Transduct Target Ther. 2024. PMID: 39169031 Free PMC article. Review.

• Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.

  Rubin L, Talmon A, Ribak Y, Lavie D, Nechushtan H, Caplan N, Lotem M, Shamriz O, Adini I, Tal Y. Rubin L, et al. J Immunother Cancer. 2024 Oct 12;12(10):e009658. doi: 10.1136/jitc-2024-009658. J Immunother Cancer. 2024. PMID: 39395838 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database